SCIO Scios Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc.

SCIO 0.01000

0.0%

Aug 19 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ausdauer who wrote (1464)	2/7/2003 9:06:00 PM
From: Miljenko Zuanic	Read Replies (2) of 1477

Congratulation to all who were long SCIO. Honestly, lately I was lining more toward short than long, but without position. <<JNJ is looking for an oral equivalent of Remicaide.>> As do all pharmas and many bios. I will continue to believe, until proven opposite, that 496 is not right molecule. Second generation or maybe one in SCIO's arsenal. However, 6-8 times Natrecor sale (two years down the road) is right price and I do not see high premium for pipeline. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next